GlycoMimetics Inc (GLYC)
0.3168
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.3133
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Total Return Price: 0.3168 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 0.3168 |
November 21, 2024 | 0.32 |
November 20, 2024 | 0.33 |
November 19, 2024 | 0.3791 |
November 18, 2024 | 0.4152 |
November 15, 2024 | 0.416 |
November 14, 2024 | 0.3994 |
November 13, 2024 | 0.402 |
November 12, 2024 | 0.3955 |
November 11, 2024 | 0.4176 |
November 08, 2024 | 0.4124 |
November 07, 2024 | 0.4201 |
November 06, 2024 | 0.3765 |
November 05, 2024 | 0.39 |
November 04, 2024 | 0.41 |
November 01, 2024 | 0.3826 |
October 31, 2024 | 0.4069 |
October 30, 2024 | 0.4565 |
October 29, 2024 | 0.49 |
October 28, 2024 | 0.1682 |
October 25, 2024 | 0.173 |
October 24, 2024 | 0.1738 |
October 23, 2024 | 0.1775 |
October 22, 2024 | 0.165 |
October 21, 2024 | 0.16 |
Date | Value |
---|---|
October 18, 2024 | 0.1584 |
October 17, 2024 | 0.1585 |
October 16, 2024 | 0.1569 |
October 15, 2024 | 0.1524 |
October 14, 2024 | 0.1486 |
October 11, 2024 | 0.1501 |
October 10, 2024 | 0.1443 |
October 09, 2024 | 0.1435 |
October 08, 2024 | 0.1528 |
October 07, 2024 | 0.156 |
October 04, 2024 | 0.1598 |
October 03, 2024 | 0.1602 |
October 02, 2024 | 0.154 |
October 01, 2024 | 0.1658 |
September 30, 2024 | 0.169 |
September 27, 2024 | 0.167 |
September 26, 2024 | 0.1705 |
September 25, 2024 | 0.1595 |
September 24, 2024 | 0.1645 |
September 23, 2024 | 0.1645 |
September 20, 2024 | 0.1648 |
September 19, 2024 | 0.17 |
September 18, 2024 | 0.164 |
September 17, 2024 | 0.165 |
September 16, 2024 | 0.1622 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.1435
Minimum
Oct 09 2024
6.16
Maximum
Dec 12 2019
2.090
Average
1.965
Median
Total Return Price Benchmarks
Biomarin Pharmaceutical Inc | 64.26 |
Arbutus Biopharma Corp | 3.51 |
Revance Therapeutics Inc | 3.73 |
FibroGen Inc | 0.3954 |
Cidara Therapeutics Inc | 20.40 |